See more : OceanFirst Financial Corp. (OCFCP) Income Statement Analysis – Financial Results
Complete financial analysis of Omkar Speciality Chemicals Limited (OMKARCHEM.NS) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Omkar Speciality Chemicals Limited, a leading company in the Chemicals – Specialty industry within the Basic Materials sector.
- HUTCHMED (China) Limited (HCM) Income Statement Analysis – Financial Results
- UnipolSai Assicurazioni S.p.A. (US.MI) Income Statement Analysis – Financial Results
- Chengdu Xiling Power Science & Technology Incorporated Company (300733.SZ) Income Statement Analysis – Financial Results
- Rito Group Corp. (RTTO) Income Statement Analysis – Financial Results
- Fusion Micro Finance Limited (FUSION.BO) Income Statement Analysis – Financial Results
Omkar Speciality Chemicals Limited (OMKARCHEM.NS)
About Omkar Speciality Chemicals Limited
Omkar Speciality Chemicals Limited manufactures and sells specialty chemicals and intermediates for chemical and allied industries in India and internationally. It provides a range of organic, inorganic, and organo inorganic intermediates. The company offers selenium derivatives, iodine derivatives, resolving agents, and advance intermediates. Its products have applications in the pharmaceuticals, neutraceuticals, fragrances and flavours, foods, poultry and veterinary, glass and ceramics, and electro plating segments. Omkar Speciality Chemicals Limited also exports its products to Europe, Canada, Asia, South America, and Australia. The company was incorporated in 1983 and is based in Thane, India.
| Metric | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 229.83M | 451.25M | 568.77M | 426.52M | 1.92B | 3.17B | 4.13B | 2.65B | 2.40B | 2.12B | 1.67B | 1.07B | 683.50M | 510.10M |
| Cost of Revenue | 167.00M | 332.36M | 498.97M | 346.24M | 2.21B | 2.44B | 3.05B | 1.89B | 1.74B | 1.40B | 1.22B | 802.12M | 502.21M | 371.61M |
| Gross Profit | 62.82M | 118.89M | 69.80M | 80.28M | -299.07M | 722.88M | 1.08B | 764.47M | 662.91M | 721.20M | 444.95M | 265.48M | 181.29M | 138.49M |
| Gross Profit Ratio | 27.34% | 26.35% | 12.27% | 18.82% | -15.61% | 22.82% | 26.20% | 28.83% | 27.59% | 34.07% | 26.65% | 24.87% | 26.52% | 27.15% |
| Research & Development | 0.00 | 392.00 | 361.00 | 2.55K | 3.16M | 45.02M | 28.67M | 17.97M | 26.55M | 19.94M | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 0.00 | 13.09M | 24.48M | 24.02M | 75.88M | 5.37M | 6.25M | 99.30M | 94.25M | 75.23M | 47.10M | 27.38M | 22.06M | 17.14M |
| Selling & Marketing | 0.00 | 1.46M | 2.17M | 23.73M | 16.02M | 16.56M | 10.81M | 7.56M | 37.18M | 30.07M | 16.00K | 0.00 | 0.00 | 0.00 |
| SG&A | 0.00 | 14.54M | 26.64M | 47.76M | 91.90M | 21.94M | 17.06M | 99.30M | 94.25M | 75.23M | 47.10M | 27.38M | 22.06M | 17.14M |
| Other Expenses | 62.82M | 6.77M | 2.40M | 17.40M | 11.38M | 201.37M | 320.52M | 241.62M | 250.55M | 295.38M | 90.73M | 41.89M | 46.90M | 35.77M |
| Operating Expenses | 62.82M | 80.40M | 134.53M | 173.20M | 216.12M | 223.31M | 337.58M | 340.92M | 344.80M | 370.61M | 137.82M | 69.27M | 68.96M | 52.91M |
| Cost & Expenses | 295.16M | 412.76M | 633.51M | 519.45M | 2.43B | 2.67B | 3.39B | 2.23B | 2.08B | 1.77B | 1.36B | 871.40M | 571.17M | 424.52M |
| Interest Income | 0.00 | 1.14M | 54.00K | 218.00K | 3.55M | 5.17M | 3.63M | 1.89M | 23.17M | 24.67M | 45.58K | 0.00 | 0.00 | 0.00 |
| Interest Expense | 60.71M | 55.02M | 49.26M | 145.28M | 240.66M | 186.19M | 188.60M | 129.76M | 131.07M | 75.22M | 80.96M | 48.48M | 37.44M | 35.96M |
| Depreciation & Amortization | 17.88M | 35.59M | 65.86M | 79.89M | 81.57M | 108.99M | 90.24M | 103.27M | 120.59M | 66.89M | 56.58M | 19.36M | 18.53M | 4.83M |
| EBITDA | -47.46M | 122.75M | 2.07M | 110.87M | -922.63M | -1.04B | 817.71M | 530.65M | 461.22M | 442.16M | 359.47M | 205.79M | 130.86M | 90.41M |
| EBITDA Ratio | -20.65% | 18.09% | 0.19% | 1.44% | -22.40% | 18.58% | 19.52% | 19.45% | 18.29% | 19.72% | 21.79% | 20.19% | 19.15% | 17.72% |
| Operating Income | -65.34M | 45.26K | -63.16K | -88.07K | -515.20M | -312.28M | 523.66M | 282.55M | 197.05M | 300.05M | 307.12M | 196.21M | 112.33M | 85.58M |
| Operating Income Ratio | -28.43% | 0.01% | -0.01% | -0.02% | -26.89% | -9.86% | 12.67% | 10.66% | 8.20% | 14.17% | 18.40% | 18.38% | 16.43% | 16.78% |
| Total Other Income/Expenses | -60.71M | 31.45M | -49.98M | -22.28M | -750.29M | -1.84B | -222.08M | -151.22M | -125.34M | -41.24M | -80.96M | -48.48M | -37.44M | -35.96M |
| Income Before Tax | -126.05M | 31.49M | -113.14M | -115.21M | -1.27B | -312.28M | 523.66M | 282.55M | 197.05M | 300.05M | 226.16M | 147.73M | 74.89M | 49.62M |
| Income Before Tax Ratio | -54.85% | 6.98% | -19.89% | -27.01% | -66.05% | -9.86% | 12.67% | 10.66% | 8.20% | 14.17% | 13.55% | 13.84% | 10.96% | 9.73% |
| Income Tax Expense | 0.00 | 11.36M | 33.23M | 53.54M | -225.80M | -56.60M | 217.53M | 39.74M | 61.45M | 94.49M | 66.16M | 45.90M | 23.05M | 18.28M |
| Net Income | -126.05M | 20.14M | -146.33M | -168.75M | -1.04B | -255.68M | 306.13M | 242.81M | 135.61M | 205.55M | 160.00M | 101.83M | 51.84M | 31.34M |
| Net Income Ratio | -54.85% | 4.46% | -25.73% | -39.56% | -54.27% | -8.07% | 7.41% | 9.16% | 5.64% | 9.71% | 9.58% | 9.54% | 7.58% | 6.14% |
| EPS | -6.13 | 0.98 | -7.11 | -8.20 | -50.52 | -12.43 | 10.79 | 12.03 | 6.91 | 10.47 | 8.15 | 5.19 | 44.97 | 27.19 |
| EPS Diluted | -6.13 | 0.98 | -7.11 | -8.20 | -50.52 | -12.43 | 10.79 | 12.03 | 6.59 | 10.46 | 8.15 | 5.19 | 44.97 | 27.19 |
| Weighted Avg Shares Out | 20.56M | 20.58M | 20.58M | 20.58M | 20.58M | 20.58M | 20.58M | 20.18M | 19.63M | 19.63M | 19.63M | 19.63M | 1.15M | 1.15M |
| Weighted Avg Shares Out (Dil) | 20.56M | 20.58M | 20.58M | 20.58M | 20.58M | 20.58M | 20.58M | 20.18M | 20.58M | 19.63M | 19.63M | 19.63M | 1.15M | 1.15M |
Source: https://incomestatements.info
Category: Stock Reports